News
Modern treatment of cystic fibrosis will be covered by VZP for children from the age of two
15. 07. 2024
Kaftrio for the Treatment of Cystic Fibrosis will now be available to children as young as two. Until now, it has only been given to patients over six. The extension of the indication was approved at the end of last year by the European Medicines Agency (EMA). General Health Insurance Company of the Czech Republic (VZP ČR) is now, in agreement with the professional society, lowering the age limit for its clients in the Czech Republic. The extension of the indication criteria comes less than two years after VZP started to cover the medicine Kaftrio for children over six years of age after meeting the given conditions. VZP has been reimbursing the drug to patients over 12 years of age since June 2021.
We published an article with other experts on neurofibromatosis
01. 07. 2024
Dr. Veronika Krulišová contributed to the article (case report) together with other experts on the topic: Neurofibromatosis, type 1: orthopaedic treatment of pseudoarthrosis of the fibula in a Czech girl, which was published in the scientific journal Pohybové ústrojí (No. 2/2023).
On this issue's front page, you will find photographs from our molecular genetics laboratory GHC Genetics, accompanied by a short article, ANALYSIS OF DNA SAMPLES BY MASSIVE PARALLEL SEQUENCING, in the editorial section.
More infoScientists identify new gene that could beat aging
18. 06. 2024
Scientists may be one step closer to unlocking the secrets to anti-aging. They've found that boosting a gene we all possess can slow the rate at which our cells wear down. The Chinese academics stumbled on the find while studying the DNA of fruit flies, when they discovered a single insect gene determined whether they died young. They ran the gene through a human database and found a 93 percent match with a human gene, known as DIMT1.
More infoMagazine
Gallery
GHC Genetics Laboratory
Helping to plant trees
Video Gallery
